Literature DB >> 23019338

Proteasomal degradation of Nod2 protein mediates tolerance to bacterial cell wall components.

Kyoung-Hee Lee1, Amlan Biswas, Yuen-Joyce Liu, Koichi S Kobayashi.   

Abstract

The innate immune system serves as the first line of defense by detecting microbes and initiating inflammatory responses. Although both Toll-like receptor (TLR) and nucleotide binding domain and leucine-rich repeat (NLR) proteins are important for this process, their excessive activation is hazardous to hosts; thus, tight regulation is required. Endotoxin tolerance is refractory to repeated lipopolysaccharide (LPS) stimulation and serves as a host defense mechanism against septic shock caused by an excessive TLR4 response during gram-negative bacterial infection. Gram-positive bacteria as well as their cell wall components also induce shock. However, the mechanism underlying tolerance is not understood. Here, we show that activation of Nod2 by its ligand, muramyl dipeptide (MDP) in the bacterial cell wall, induces rapid degradation of Nod2, which confers MDP tolerance in vitro and in vivo. Nod2 is constitutively associated with a chaperone protein, Hsp90, which is required for Nod2 stability and protects Nod2 from degradation. Upon MDP stimulation, Hsp90 rapidly dissociates from Nod2, which subsequently undergoes ubiquitination and proteasomal degradation. The SOCS-3 protein induced by Nod2 activation further facilitates this degradation process. Therefore, Nod2 protein stability is a key factor in determining responsiveness to MDP stimulation. This indicates that TLRs and NLRs induce a tolerant state through distinct molecular mechanisms that protect the host from septic shock.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23019338      PMCID: PMC3501029          DOI: 10.1074/jbc.M112.410027

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  69 in total

1.  IRAK-M is a negative regulator of Toll-like receptor signaling.

Authors:  Koichi Kobayashi; Lorraine D Hernandez; Jorge E Galán; Charles A Janeway; Ruslan Medzhitov; Richard A Flavell
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

2.  Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract.

Authors:  Koichi S Kobayashi; Mathias Chamaillard; Yasunori Ogura; Octavian Henegariu; Naohiro Inohara; Gabriel Nuñez; Richard A Flavell
Journal:  Science       Date:  2005-02-04       Impact factor: 47.728

Review 3.  Pathophysiology of interleukin-1 receptor-associated kinase-M: implications in refractory state.

Authors:  Eduardo López-Collazo; Pablo Fuentes-Prior; Francisco Arnalich; Carlos del Fresno
Journal:  Curr Opin Infect Dis       Date:  2006-06       Impact factor: 4.915

4.  NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses.

Authors:  Konstantin D Taganov; Mark P Boldin; Kuang-Jung Chang; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-02       Impact factor: 11.205

5.  Prevention of experimental septic shock by pretreatment of mice with muramyl peptides.

Authors:  E Meshcheryakova; S Guryanova; E Makarov; L Alekseeva; T Andronova; V Ivanov
Journal:  Int Immunopharmacol       Date:  2001-09       Impact factor: 4.932

6.  Blau syndrome mutation of CARD15/NOD2 in sporadic early onset granulomatous arthritis.

Authors:  Carlos D Rosé; Trudy M Doyle; Gail McIlvain-Simpson; Jessica E Coffman; James T Rosenbaum; Michael P Davey; Tammy M Martin
Journal:  J Rheumatol       Date:  2005-02       Impact factor: 4.666

Review 7.  Molecular mechanisms of endotoxin tolerance.

Authors:  Hongkuan Fan; James A Cook
Journal:  J Endotoxin Res       Date:  2004

8.  Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome.

Authors:  Nobuo Kanazawa; Ikuo Okafuji; Naotomo Kambe; Ryuta Nishikomori; Mami Nakata-Hizume; Sonoko Nagai; Akihiko Fuji; Takenosuke Yuasa; Akira Manki; Yoshihiko Sakurai; Mitsuru Nakajima; Hiroko Kobayashi; Ikuma Fujiwara; Hiroyuki Tsutsumi; Atsushi Utani; Chikako Nishigori; Toshio Heike; Tatsutoshi Nakahata; Yoshiki Miyachi
Journal:  Blood       Date:  2004-09-30       Impact factor: 22.113

9.  Ubiquitin-editing enzyme A20 promotes tolerance to lipopolysaccharide in enterocytes.

Authors:  Jin Wang; Yannan Ouyang; Yigit Guner; Henri R Ford; Anatoly V Grishin
Journal:  J Immunol       Date:  2009-07-01       Impact factor: 5.422

10.  Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis.

Authors:  Tomohiro Watanabe; Naoki Asano; Peter J Murray; Keiko Ozato; Prafullakumar Tailor; Ivan J Fuss; Atsushi Kitani; Warren Strober
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

View more
  36 in total

Review 1.  NOD proteins: regulators of inflammation in health and disease.

Authors:  Dana J Philpott; Matthew T Sorbara; Susan J Robertson; Kenneth Croitoru; Stephen E Girardin
Journal:  Nat Rev Immunol       Date:  2013-12-13       Impact factor: 53.106

Review 2.  International Union of Basic and Clinical Pharmacology. XCVI. Pattern recognition receptors in health and disease.

Authors:  Clare E Bryant; Selinda Orr; Brian Ferguson; Martyn F Symmons; Joseph P Boyle; Tom P Monie
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

Review 3.  Understanding the regulation of pattern recognition receptors in inflammatory diseases - a 'Nod' in the right direction.

Authors:  Claire L Feerick; Declan P McKernan
Journal:  Immunology       Date:  2016-11-14       Impact factor: 7.397

4.  Molecular mechanisms of biogenesis of apoptotic exosome-like vesicles and their roles as damage-associated molecular patterns.

Authors:  Soo Jeong Park; Jeong Mi Kim; Jihyo Kim; Jaehark Hur; Sun Park; Kyongmin Kim; Ho-Joon Shin; Yong-Joon Chwae
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-21       Impact factor: 11.205

5.  Peptidoglycan Modifications Tune the Stability and Function of the Innate Immune Receptor Nod2.

Authors:  James E Melnyk; Vishnu Mohanan; Amy K Schaefer; Ching-Wen Hou; Catherine Leimkuhler Grimes
Journal:  J Am Chem Soc       Date:  2015-06-02       Impact factor: 15.419

6.  Foot-and-Mouth Disease Virus Antagonizes NOD2-Mediated Antiviral Effects by Inhibiting NOD2 Protein Expression.

Authors:  Huisheng Liu; Zixiang Zhu; Qiao Xue; Fan Yang; Weijun Cao; Keshan Zhang; Xiangtao Liu; Haixue Zheng
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

7.  Helicobacter pylori infection causes hepatic insulin resistance by the c-Jun/miR-203/SOCS3 signaling pathway.

Authors:  Xiaoying Zhou; Wei Liu; Min Gu; Hongwen Zhou; Guoxin Zhang
Journal:  J Gastroenterol       Date:  2015-02-19       Impact factor: 7.527

8.  The molecular chaperone HSP70 binds to and stabilizes NOD2, an important protein involved in Crohn disease.

Authors:  Vishnu Mohanan; Catherine Leimkuhler Grimes
Journal:  J Biol Chem       Date:  2014-04-30       Impact factor: 5.157

Review 9.  RIP2 activity in inflammatory disease and implications for novel therapeutics.

Authors:  Janice C Jun; Fabio Cominelli; Derek W Abbott
Journal:  J Leukoc Biol       Date:  2013-06-21       Impact factor: 4.962

Review 10.  NOD1 and NOD2: signaling, host defense, and inflammatory disease.

Authors:  Roberta Caruso; Neil Warner; Naohiro Inohara; Gabriel Núñez
Journal:  Immunity       Date:  2014-12-06       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.